14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 WINT stock ended at $4.77. This is 8.41% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 10.40% from a day low at $4.42 to a day high of $4.88.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Windtree Therapeutics Inc prices

Date Open High Low Close Volume
May 11, 2022 $0.639 $0.640 $0.490 $0.516 522 565
May 10, 2022 $0.630 $0.653 $0.601 $0.625 284 340
May 09, 2022 $0.664 $0.665 $0.600 $0.625 337 022
May 06, 2022 $0.730 $0.738 $0.657 $0.669 377 228
May 05, 2022 $0.720 $0.750 $0.720 $0.725 147 144
May 04, 2022 $0.770 $0.770 $0.723 $0.730 123 373
May 03, 2022 $0.724 $0.780 $0.717 $0.769 308 317
May 02, 2022 $0.750 $0.760 $0.720 $0.728 113 838
Apr 29, 2022 $0.750 $0.770 $0.721 $0.740 187 878
Apr 28, 2022 $0.775 $0.788 $0.740 $0.770 296 822
Apr 27, 2022 $0.750 $0.778 $0.736 $0.770 346 479
Apr 26, 2022 $0.772 $0.785 $0.731 $0.740 359 082
Apr 25, 2022 $0.80 $0.83 $0.731 $0.780 955 707
Apr 22, 2022 $0.84 $0.87 $0.80 $0.81 685 994
Apr 21, 2022 $0.96 $0.98 $0.85 $0.87 2 712 999
Apr 20, 2022 $1.40 $1.43 $0.97 $1.02 34 435 633
Apr 19, 2022 $0.98 $1.02 $0.97 $1.00 132 796
Apr 18, 2022 $1.03 $1.09 $0.98 $0.98 122 915
Apr 14, 2022 $1.05 $1.10 $1.03 $1.07 64 030
Apr 13, 2022 $1.03 $1.10 $1.02 $1.05 57 501
Apr 12, 2022 $1.05 $1.09 $1.03 $1.03 21 481
Apr 11, 2022 $1.01 $1.09 $0.97 $1.06 33 961
Apr 08, 2022 $1.09 $1.09 $1.05 $1.05 18 189
Apr 07, 2022 $1.12 $1.12 $1.05 $1.07 42 107
Apr 06, 2022 $1.14 $1.14 $1.10 $1.10 50 978
Click to get the best stock tips daily for free!

About Windtree Therapeutics Inc

Windtree Therapeutics Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF,... WINT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT